Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sharp Shalini
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   215,117    

Indirect Shares

   104,270      
Direct Value   $4,317,035    

Indirect Value

   $46,244      
Total Shares   319,387      
Total Value   $4,363,279      


Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $3,780,434 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $135,840 Agenus Inc $36,061 Ultragenyx Pharmaceutical Inc $3,780,434 Nuvation Bio Ord Shs Class A $364,700 Neurocrine Biosciences Inc $135,840
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    6    

     Stock price went up :
    0   
    5    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   5.0   
     Percentage Gain/Loss :
     0.0%
 537.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Agenus Inc AGEN Director 2013-01-30 81,311 2015-09-28 104,270    Premium*  
            Ultragenyx Pharmaceutical Inc RARE EVP, Finance 2020-10-14 97,812 0    Premium*  
            Nuvation Bio Ord Shs Class A NUVB Director 2021-02-10 35,000 2021-02-10 0    Premium*  
            Mirati Therapeutics, Inc. MRTX 2024-01-23 0 2021-03-26 0    Premium*  
            Neurocrine Biosciences Inc NBIX Director 2024-05-17 994 2024-05-17 0    Premium*  
* Premium Members only  

Records found :    130         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 4 of 6
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-02-27 4 OE $0.82 $9,780 D/D 12,000 63,887 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-02-27 4 AS $80.14 $961,680 D/D (12,000) 51,887 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-03-01 4 A $0.00 $0 D/D 4,000 55,887 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-05-21 4 D $57.47 $23,793 D/D (414) 55,846 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2017-06-01 4 D $56.61 $21,285 D/D (376) 55,470 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-03-01 4 A $0.00 $0 D/D 7,000 62,510 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-03-01 4 D $48.43 $19,227 D/D (397) 62,113 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-04-19 4 A $0.00 $0 D/D 1,431 63,544 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-05-21 4 D $64.79 $24,685 D/D (381) 63,674 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-05-30 4 OE $0.82 $5,298 D/D 6,500 70,174 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-05-30 4 AS $70.17 $912,171 D/D (13,000) 57,174 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-06-01 4 D $73.73 $25,511 D/D (346) 56,828 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-06-07 4 OE $0.82 $2,730 D/D 3,350 60,178 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-06-07 4 AS $80.07 $536,456 D/D (6,700) 53,478 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-09-25 4 AS $90.07 $603,469 D/D (6,700) 50,128 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-09-25 4 OE $0.82 $2,730 D/D 3,350 56,828 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2018-10-31 4 OE $0.82 $9,780 D/D 12,000 62,128 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-01 4 A $0.00 $0 D/D 8,000 70,137 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-01 4 D $67.55 $66,267 D/D (981) 69,156 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-05 4/A S $65.52 $66,306 D/D (1,012) 69,125 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4/A AS $70.00 $1,036,000 D/D (14,800) 66,326 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4/A OE $6.86 $82,320 D/D 12,000 81,126 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4 AS $70.00 $1,036,000 D/D (14,800) 66,357 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-03-18 4 OE $6.86 $82,320 D/D 12,000 81,157 0 -
RARE Ultragenyx Pharmaceutical... CFO & Executive Vice President   •       –      –    2019-04-19 4 D $64.43 $15,979 D/D (248) 66,078 0 -
  130  Records found
  1   2   3   4  5   6      
  Page 4 of 6  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us